Investment Firm Closes Biotech Stake, SEC Filing
A big investment firm has exited its complete stake in a biotech company, disclosed in an SEC filing. The move provid...
Systematic budget analysis reveals errors and inefficiencies. This primer shows how to review income, expenses, and allocations effectively.
17,750 articlesA big investment firm has exited its complete stake in a biotech company, disclosed in an SEC filing. The move provid...
A 10% move in Vericel stock drew attention after a COO sold shares worth $402,000. This article breaks down what the ...
Investors are watching Sinclair (SBGI) 2025 earnings closely as local ad markets and political cycles shape cash flow...
A notable institutional purchase in Plains GP Holdings hints at a larger, value-driven view of the energy midstream s...
The memory market is cyclical, and July 10 could bring a stock-moving catalyst for Micron. This guide breaks down why...
When Hamilton Beach reports earnings, investors gain clues about demand for small appliances and margin discipline. T...
When a high-ranking insider sells stock, investors want to know what it means. This guide breaks down the implication...
A recent FDA decision sparked a powerful rally in Moderna shares, but is the move enough to call it a no-brainer? Thi...
A high-stakes moment at Davos shifted sentiment in crypto markets. Michael Saylor announced a record BTC purchase, wh...
When a biotech stock jumps after a conference, investors want to know if it’s sustainable. This article breaks down w...
Biotech investing often rides on data, not on dreams. This educational piece uses a fictional company to show how wal...
A major investment firm boosted its Dyne Therapeutics stake by nearly $4 million, highlighting renewed interest in DY...